CYTIMMUNE SCIENCES
History
| Year | Detail |
|---|---|
| 1988 | The company was founded in 1988 as a research diagnostics supplier with expertise in immune system components including cytokine and antibody production, detection, and manipulation. |
| 2020 | CytImmune signed an agreement with the Tokyo University of Science, Division of Molecular Regulation of Inflammation and Immune Diseases, to investigate and confirm the link between Cytimmune’s nanomedicines and existing checkpoint inhibitors. |
| 2021 | Cytimmune and the U.S. Nanotechnology Characterization Laboratory signed a Material Transfer Agreement (MTA) to develop a new nanomedicine construct that simultaneously delivers Interferon-gamma (IFN-y) and Tumor Necrosis Factor-alpha (TNF alpha) on the same gold nanoparticle. |
BCC Research Beacon 